Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1
- 31 December 2011
- journal article
- Published by Elsevier BV in Cellular Immunology
- Vol. 271 (2), 392-400
- https://doi.org/10.1016/j.cellimm.2011.08.007
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Bryostatin-1, a Naturally Occurring Antineoplastic Agent, Acts as a Toll-like Receptor 4 (TLR-4) Ligand and Induces Unique Cytokines and Chemokines in Dendritic CellsJournal of Biological Chemistry, 2011
- Pro-cathepsin D interacts with the extracellular domain of the β chain of LRP1 and promotes LRP1-dependent fibroblast outgrowthJournal of Cell Science, 2010
- MHC II lung cancer vaccines prime and boost tumor‐specific CD4+ T cells that cross‐react with multiple histologic subtypes of nonsmall cell lung cancer cellsInternational Journal of Cancer, 2010
- Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by MelanomaJournal of Oncology, 2009
- Oscillating Cortical Thick Ascending Limb Cells at the Juxtaglomerular ApparatusJournal of the American Society of Nephrology, 2008
- Phenotype and Functional Characterization of Long-term gp100-Specific Memory CD8+ T Cells in Disease-Free Melanoma Patients Before and After Boosting ImmunizationClinical Cancer Research, 2008
- The known unknowns of antigen processing and presentationNature Reviews Immunology, 2008
- Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanomaCancer Immunology, Immunotherapy, 2008
- Immune surveillance: a balance between protumor and antitumor immunityCurrent Opinion in Genetics & Development, 2008
- Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cellsCellular Immunology, 2007